Everest Medicines VELSIPITY application for localized manufacturing accepted in China

Everest Medicines announced that China's National Medical Products Administration (NMPA) has accepted its application for localized manufacturing of VELSIPITY (etrasimod arginine tablets) and granted Priority Review.